Tissue-Resident Lymphocytes: Implications in Immunotherapy for Hepatocellular Carcinoma
Ji Won Han(The Catholic University of Korea Seoul St. Mary's Hospital), Seung Kew Yoon(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 9
Related Papers
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1
|Journal for ImmunoTherapy of Cancer|2020|116
Branched-Chain Amino Acids Ameliorate Fibrosis and Suppress Tumor Growth in a Rat Model of Hepatocellular Carcinoma with Liver Cirrhosis
|PLoS ONE|2013|47
Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
|Pharmaceutics|2021|42
Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133
|Scientific Reports|2017|39